+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Healthcare CRO Services Market, by Service Type, by End User, by Therapeutic Area, by Country, Industry Analysis and Forecast, 2019 - 2025

  • ID: 5017777
  • Report
  • March 2020
  • Region: North America
  • 96 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • ICON PLC
  • IQVIA Holdings, Inc.
  • Syneos Health, Inc.
The North America Healthcare CRO Market is expected to witness market growth of 5.6% CAGR during the forecast period (2019-2025).

The healthcare industry has been to the big data party late. Nonetheless, as the adoption of big data for healthcare continues to evolve, it will gradually follow other industries' more complex consumer marketing behaviors. This maturation is focused on acknowledgment by health care leaders that they need to take a broader and more strategic view of the knowledge. Healthcare data management I Information management in healthcare is the process of preserving, securing and evaluating information derived from different sources. Managing the abundance of available data on healthcare allows health systems to create comprehensive patient experiences, customized treatments, enhance communication, and improve health outcomes.

Real-time health monitoring systems offer real-time analyses of the health parameters for the patient. Through these devices, patients exchange their health-care details with their providers in real-time for flexible health monitoring and management. The Internet of medical things significantly improves patients' health-care conditions. Due to the usage of the above IoT medical devices in the healthcare sector, tracking of patient monitoring and drug management has become possible. A growing aging population, increasing healthcare costs and a rise in the prevalence of chronic diseases are causing stakeholders in healthcare to strongly pursue remote health management and patient monitoring.

Based on Service Type, the market is segmented into Clinical Research Services, Early Phase Development, Laboratory Services and Consulting Services. Based on End User, the market is segmented into Pharmaceutical companies, Medical Device Companies and Academic Institutes. Based on Therapeutic Area, the market is segmented into Oncology, CNS Disorder, Cardiovascular Disease, Diabetes, Metabolic Diseases, Infectious Diseases and Other therapeutic areas. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., Laboratory Corporation of America Holdings (Covance, Inc.), Pharmaceutical Product Development, Inc., Parexel International Corporation (Pamplona Capital Management), Charles River Laboratories International, Inc., ICON PLC, Dassault Systemes SE (Medidata Solutions, Inc.), Syneos Health, Inc., Pharmaron Beijing Co., Ltd., and GVK Biosciences Private Limited.

Scope of the Study

Market Segmentation:

By Service Type
  • Clinical Research Services
  • Early Phase Development
  • Laboratory Services and
  • Consulting Services

By End User
  • Pharmaceutical companies
  • Medical Device Companies and
  • Academic Institutes

By Therapeutic Area
  • Oncology
  • CNS Disorder
  • Cardiovascular Disease
  • Diabetes
  • Metabolic Diseases
  • Infectious Diseases and
  • Other therapeutic areas

By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled
  • IQVIA Holdings, Inc.
  • Laboratory Corporation of America Holdings (Covance, Inc.)
  • Pharmaceutical Product Development, Inc.
  • Parexel International Corporation (Pamplona Capital Management)
  • Charles River Laboratories International, Inc.
  • ICON PLC
  • Dassault Systemes SE (Medidata Solutions, Inc.)
  • Syneos Health, Inc.
  • Pharmaron Beijing Co., Ltd.
  • GVK Biosciences Private Limited

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ICON PLC
  • IQVIA Holdings, Inc.
  • Syneos Health, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Healthcare CRO Services Market, by Service Type
1.4.2 North America Healthcare CRO Services Market, by End User
1.4.3 North America Healthcare CRO Services Market, by Therapeutic Area
1.4.4 North America Healthcare CRO Services Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Aug – 2020, Mar) Leading Players
Chapter 4. North America Healthcare CRO Services Market by Service Type
4.1 North America Clinical Research Services Market by Country
4.2 North America Early Phase Development Market by Country
4.3 North America Laboratory Services Market by Country
4.4 North America Consulting Services Market by Country
Chapter 5. North America Healthcare CRO Services Market by End User
5.1 North America Pharmaceutical Sector Market by Country
5.2 North America Medical Device Sector Market by Country
5.3 North America Academic Institutes Market by Country
Chapter 6. North America Healthcare CRO Services Market by Therapeutic Areas
6.1 North America Oncology Market by Country
6.2 North America CNS Disorder Market by Country
6.3 North America Cardiovascular Disease Market by Country
6.4 North America Diabetes Market by Country
6.5 North America Metabolic Diseases Market by Country
6.6 North America Infectious Diseases Market by Country
6.7 North America Other therapeutic areas Market by Country
Chapter 7. North America Healthcare CRO Services Market by Country
7.1 US Healthcare CRO Services Market
7.1.1 US Healthcare CRO Services Market by Service Type
7.1.2 US Healthcare CRO Services Market by End User
7.1.3 US Healthcare CRO Services Market by Therapeutic Areas
7.2 Canada Healthcare CRO Services Market
7.2.1 Canada Healthcare CRO Services Market by Service Type
7.2.2 Canada Healthcare CRO Services Market by End User
7.2.3 Canada Healthcare CRO Services Market by Therapeutic Areas
7.3 Mexico Healthcare CRO Services Market
7.3.1 Mexico Healthcare CRO Services Market by Service Type
7.3.2 Mexico Healthcare CRO Services Market by End User
7.3.3 Mexico Healthcare CRO Services Market by Therapeutic Areas
7.4 Rest of North America Healthcare CRO Services Market
7.4.1 Rest of North America Healthcare CRO Services Market by Service Type
7.4.2 Rest of North America Healthcare CRO Services Market by End User
7.4.3 Rest of North America Healthcare CRO Services Market by End User
Chapter 8. Company Profiles
8.1 IQVIA Holdings, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Recent strategies and developments:
8.1.4.1 Product Launches and Product Expansions:
8.2 Laboratory Corporation of America Holdings (Covance, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.1 Recent strategies and developments:
8.2.1.1 Product Launches and Product Expansions:
8.2.1.2 Acquisition and Mergers:
8.2.1.3 Geographical Expansions:
8.3 Pharmaceutical Product Development, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Geographical Expansions:
8.3.4.2 Acquisition and Mergers:
8.3.4.3 Partnerships, Collaborations, and Agreements:
8.4 Parexel International Corporation (Pamplona Capital Management)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Partnerships, Collaborations, and Agreements:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.4.2 Partnerships, Collaborations, and Agreements:
8.6 ICON PLC
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Product Launches and Product Expansions:
8.6.4.2 Acquisition and Mergers:
8.6.4.3 Partnerships, Collaborations, and Agreements:
8.7 Dassault Systemes SE (Medidata Solutions, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Syneos Health, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Recent strategies and developments:
8.8.4.1 Partnerships, Collaborations, and Agreements:
8.9 Pharmaron Beijing Co., Ltd.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.1 GVK Biosciences Private Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Note: Product cover images may vary from those shown
  • IQVIA Holdings, Inc.
  • Laboratory Corporation of America Holdings (Covance, Inc.)
  • Pharmaceutical Product Development, Inc.
  • Parexel International Corporation (Pamplona Capital Management)
  • Charles River Laboratories International, Inc.
  • ICON PLC
  • Dassault Systemes SE (Medidata Solutions, Inc.)
  • Syneos Health, Inc.
  • Pharmaron Beijing Co., Ltd.
  • GVK Biosciences Private Limited
Note: Product cover images may vary from those shown

Loading
LOADING...